Systematic Review: Efficacy of Medical Therapy on Outcomes Important to Adult Patients with X-Linked Hypophosphatemia

DS Ali, RD Mirza, F Alsarraf, S Hussein… - The Journal of …, 2024 - academic.oup.com
Objective To examine the highest certainty evidence addressing the management of X-
linked hypophosphatemia (XLH) in adults to inform treatment recommendations. Methods …

Characteristics of patients with rheumatic heart disease in a national referral hospital in Indonesia

E Rudiktyo, A Windi, P Doevendans, B Budi Siswanto… - 2022 - repository.unar.ac.id
Characteristics of patients with rheumatic heart disease in a national referral hospital in
Indonesia Estu Rudiktyo, 1 Annemieke Wind, 2, 3 Pieter Doevendans, 3, 4, 5 Bambang Budi …

Altered expression of transfer-RNA-Derived small RNAs in human with rheumatic heart disease

Z Yang, P Li, Z Li, T Tang, W Liu… - Frontiers in Cardiovascular …, 2021 - frontiersin.org
Rheumatic heart disease (RHD) remains a severe public health problem in developing
countries. Atrial fibrillation (AF) is a medical complication of RHD. Although the …

[HTML][HTML] Procedural success and outcomes after percutaneous balloon mitral valvuloplasty in rheumatic mitral stenosis with moderate mitral regurgitation: a …

P Chichareon, T Nilmoje, S Suwanugsorn… - Cardiovascular …, 2022 - ncbi.nlm.nih.gov
Background Percutaneous balloon mitral valvuloplasty (PBMV) is contraindicated in mitral
stenosis (MS) with moderate mitral regurgitation (MR) according to the European guidelines …

Incidence and predictors of adverse outcomes in patients with rheumatic mitral stenosis following percutaneous balloon mitral valvuloplasty: a study from a tertiary …

K Songduang, Y Kaolawanich, K Karaketklang… - BMC Cardiovascular …, 2024 - Springer
Background Rheumatic mitral stenosis (MS) remains a common and concerning health
problem in Asia. Percutaneous balloon mitral valvuloplasty (PBMV) is the standard treatment …

Immediate and short-term outcomes of percutaneous balloon mitral commissurotomy for severe mitral stenosis at a Resource Limited Setting, Addis Ababa, Ethiopia

M Mamo, E Woldeyes, S Zegeye, S Feleke… - Progress in Pediatric …, 2024 - Elsevier
Background Rheumatic heart disease is a common cause of mitral stenosis (MS) in
developing nations. Percutaneous mitral balloon commissurotomy (PMBC) is the treatment …

20-year follow-up of rheumatic mitral stenosis patients after percutaneous mitral commissurotomy: invasive transmitral gradient differential as a predictor of events

AF Amador, C Costa, R Pinto… - … Archives for Chest …, 2024 - monaldi-archives.org
Percutaneous mitral valve commissurotomy (PMC) is a viable alternative to mitral valve (MV)
surgery in the treatment of patients with rheumatic mitral stenosis (RMS). In this single-center …

Early intervention for asymptomatic mitral stenosis: a stitch in time?

G Karthikeyan - Heart, 2021 - heart.bmj.com
For patients with symptomatic severe mitral stenosis (MS), percutaneous transvenous mitral
commissurotomy (PTMC) using an Inoue (or Inoue-like) balloon is the most reasonable …

Percutaneous transvenous mitral commissurotomy in rheumatic mitral stenosis with atrial dysfunction. Opening the valve… and a window of opportunity

M Foppa, ABS Santos - The International Journal of Cardiovascular …, 2022 - Springer
12. Sonaglioni A, Vincenti A, Baravelli M et al (2019) Prognostic value of global left atrial
peak strain in patients with acute ischemic stroke and no evidence of atrial fibrillation. Int J …

[PDF][PDF] Immediate post-procedural complications of Percutaneous Transvenous Mitral Commissurotomy (PTMC) with special reference to Valvular and Neurologic …

TM Khan, HM Zarif, A Akhtar, I Fareed, GZ Niazi… - Isra Med J, 2021 - imj.com.pk
Objective: To assess the frequency of worsening pre-existing mitral regurgitation,
development of new mitral regurgitation and the evidence of cerebral embolization in …